|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of operating right of use asset | |||||
| Amortization of loan discount | |||||
| Stock compensation expense | |||||
| Gain on termination of operating lease | |||||
| Unrealized gain (loss) on investments | |||||
| Net amortization/accretion | |||||
| Realized loss on investments | |||||
| Common stock received in settlement of accounts receivable | |||||
| Deferred income tax benefit | |||||
| Bad debt expense | |||||
| (Increase) decrease in: | |||||
| Accounts receivables | |||||
| Operating right of use asset | |||||
| Contract assets and unbilled receivables | |||||
| Long-term receivables, prepaids and other assets | |||||
| Increase (decrease) in: | |||||
| Accounts payable | |||||
| Operating lease liability | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Issuance of note receivable | |||||
| Purchase of property and equipment | |||||
| Capitalization of software development costs | |||||
| Purchase of marketable securities | |||||
| Investment deposit | |||||
| Capitalization of software development costs in progress | |||||
| Sale (purchase) of marketable securities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net (decrease) in lines of credit | |||||
| Common stock buyback/retirement | |||||
| Redemption of Series B Preferred | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from employee stock plan | |||||
| Dividends paid | |||||
| Payments on notes payable and capital leases | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Cash paid for operating leases | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities | |||||
| Common Stock to pay accrued liabilities (in shares) | |||||
| Common Stock to pay accrued liabilities | |||||
| Total common Stock to pay accrued liabilities | |||||
| Dividends accrued on Preferred Stock | |||||
| Right of use asset | |||||
Loading...